Goldman Sachs Maintains Buy on Aptiv, Lowers Price Target to $61

Benzinga Newsdesk www.benzinga.com Neutral 52.8%

Neg 0% Neu 52.8% Pos 0%

Goldman Sachs analyst Mark Delaney maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $71 to $61.

Comments

No comments yet. Be the first!